Correction to: Efficacy and safety of ixekizumab in patients with active psoriatic arthritis with and without concomitant conventional disease-modifying antirheumatic drugs: SPIRIT-P1 and SPIRIT-P2 3-year results.

Publication Title

Clinical rheumatology

Document Type

Article

Publication Date

7-11-2022

Keywords

washington; swedish

Clinical Institute

Orthopedics & Sports Medicine

Specialty

Rheumatology

Specialty

Orthopedics

Share

COinS